A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.

Harrold, Leslie R; Zueger, Patrick; Nowell, W Benjamin; Blachley, Taylor; Schrader, Amy; Lakin, Paul R; Curtis, David; Stradford, Laura; Venkatachalam, Shilpa; Tundia, Namita; Patel, Pankaj A

Harrold, Leslie R; Zueger, Patrick; Nowell, W Benjamin; Blachley, Taylor; Schrader, Amy; Lakin, Paul R; Curtis, David; Stradford, Laura; Venkatachalam, Shilpa; Tundia, Namita; Patel, Pankaj A.

Afiliação

Harrold LR; CorEvitas, LLC, 300 5th Avenue, Waltham, MA, 02451, USA. lharrold@corevitas.com.
Zueger P; University of Massachusetts Medical School, Worcester, MA, USA. lharrold@corevitas.com.
Nowell WB; AbbVie Inc., North Chicago, IL, USA.
Blachley T; Global Healthy Living Foundation, Upper Nyack, NY, USA.
Schrader A; CorEvitas, LLC, 300 5th Avenue, Waltham, MA, 02451, USA.
Lakin PR; CorEvitas, LLC, 300 5th Avenue, Waltham, MA, 02451, USA.
Curtis D; CorEvitas, LLC, 300 5th Avenue, Waltham, MA, 02451, USA.
Stradford L; Global Healthy Living Foundation, Upper Nyack, NY, USA.
Venkatachalam S; Global Healthy Living Foundation, Upper Nyack, NY, USA.
Tundia N; Global Healthy Living Foundation, Upper Nyack, NY, USA.
Patel PA; AbbVie Inc., North Chicago, IL, USA.

Rheumatol Ther ; 10(6): 1519-1533, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37728861

Palavras-chave

CorEvitas; Digital health; Janus kinase (JAK) inhibitor; Observational; Patient-reported outcomes; Prospective; Real-world effectiveness; Rheumatoid arthritis; Routine Assessment of Patient Index Data 3 (RAPID3); Upadacitinib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google